infection but perform poorly at distinguishing active tuberculosis disease (ATB) and latent tuberculosis infection (LTBI). This study is aimed at evaluating additional cytokines as biomarkers besides interferon-gamma (IFN-γ) to improve the identification of ATB and LTBI. exposure time and the degree of smear-positivity of the index cases. The IL-2/IFN-γ ratio in the antigen-stimulated plasma could discriminate LTBI from ATB with a sensitivity of 77.2% and a specificity of 87.2%.-specific antigen-stimulated expression of IP-10 and IL-2 may be useful for detecting both ATB and LTBI. Combining the QFT with IP-10 and IL-2 could increase the detection accuracy of active TB over the QFT alone
We read with interest the recent article by Wergeland et al., reporting that serum interferon-gamma ...
We read with interest the recent article by Wergeland et al., reporting that serum interferon-gamma ...
We read with interest the recent article by Wergeland et al., reporting that serum interferon-gamma ...
infection but perform poorly at distinguishing active tuberculosis disease (ATB) and latent tubercu...
Background: The Mycobacterium tuberculosis (Mtb)-specific T-cell interferon gamma release assays (IG...
Interferon gamma release assays (IGRAs) could accurately diagnose Mycobacterium tuberculosis (M.tube...
In the absence of a gold standard for the diagnosis of latent tuberculosis (TB) infection (LTBI), th...
Effective control of tuberculosis (TB) includes discrimination of subjects with active TB from indiv...
Abstract Background The early and accurate diagnosis of tuberculosis (TB) is critical for controllin...
The aim of the present study was to evaluate the potential of diagnostic tests based on interferon-g...
RATIONALE: Current immunodiagnostic tests for tuberculosis (TB), including the tuberculin skin test ...
AbstractEffective control of tuberculosis (TB) includes discrimination of subjects with active TB fr...
The development of clinically relevant biomarkers is important for diagnosing latent tuberculosis in...
BACKGROUND: There is a need for reliable markers to diagnose active and latent tuberculosis (TB). Th...
Objectives New tests are needed to overcome the limitations of existing immunodiagnostic tests for t...
We read with interest the recent article by Wergeland et al., reporting that serum interferon-gamma ...
We read with interest the recent article by Wergeland et al., reporting that serum interferon-gamma ...
We read with interest the recent article by Wergeland et al., reporting that serum interferon-gamma ...
infection but perform poorly at distinguishing active tuberculosis disease (ATB) and latent tubercu...
Background: The Mycobacterium tuberculosis (Mtb)-specific T-cell interferon gamma release assays (IG...
Interferon gamma release assays (IGRAs) could accurately diagnose Mycobacterium tuberculosis (M.tube...
In the absence of a gold standard for the diagnosis of latent tuberculosis (TB) infection (LTBI), th...
Effective control of tuberculosis (TB) includes discrimination of subjects with active TB from indiv...
Abstract Background The early and accurate diagnosis of tuberculosis (TB) is critical for controllin...
The aim of the present study was to evaluate the potential of diagnostic tests based on interferon-g...
RATIONALE: Current immunodiagnostic tests for tuberculosis (TB), including the tuberculin skin test ...
AbstractEffective control of tuberculosis (TB) includes discrimination of subjects with active TB fr...
The development of clinically relevant biomarkers is important for diagnosing latent tuberculosis in...
BACKGROUND: There is a need for reliable markers to diagnose active and latent tuberculosis (TB). Th...
Objectives New tests are needed to overcome the limitations of existing immunodiagnostic tests for t...
We read with interest the recent article by Wergeland et al., reporting that serum interferon-gamma ...
We read with interest the recent article by Wergeland et al., reporting that serum interferon-gamma ...
We read with interest the recent article by Wergeland et al., reporting that serum interferon-gamma ...